Suchbegriffe: CIRCULATING TUMOR CELLS, . Treffer: 59
Trapp, EK; Fasching, PA; Fehm, T; Schneeweiss, A; Mueller, V; Harbeck, N; Lorenz, R; Schumacher, C; Heinrich, G; Schochter, F; de Gregorio, A; Tzschaschel, M; Rack, B; Janni, W; Friedl, TWP
Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis-Results from the Adjuvant SUCCESS A Trial
CANCERS. 2022; 14(16): 3949
Doi: 10.3390/cancers14163949
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Suppan, C
Post San Antonio update-my top three abstracts!
MEMO-MAG EUR MED ONC. 2021;
Doi: 10.1007/s12254-021-00718-0
Web of Science
FullText
FullText_MUG
Hofmann, L; Kroneis, T; El-Heliebi, A
Using In Situ Padlock Probe Technology to Detect mRNA Splice Variants in Tumor Cells.
Methods Mol Biol. 2020; 2148: 361-378.
Doi: 10.1007/978-1-0716-0623-0_23
PubMed
FullText
FullText_MUG
Hofmann, L; Sallinger, K; Haudum, C; Smolle, M; Heitzer, E; Moser, T; Novy, M; Gesson, K; Kroneis, T; Bauernhofer, T; El-Heliebi, A
A Multi-Analyte Approach for Improved Sensitivity of Liquid Biopsies in Prostate Cancer.
Cancers (Basel). 2020; 12(8):
Doi: 10.3390/cancers12082247
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Koch, C; Kuske, A; Joosse, SA; Yigit, G; Sflomos, G; Thaler, S; Smit, DJ; Werner, S; Borgmann, K; Gärtner, S; Mossahebi Mohammadi, P; Battista, L; Cayrefourcq, L; Altmüller, J; Salinas-Riester, G; Raithatha, K; Zibat, A; Goy, Y; Ott, L; Bartkowiak, K; Tan, TZ; Zhou, Q; Speicher, MR; Müller, V; Gorges, TM; Jücker, M; Thiery, JP; Brisken, C; Riethdorf, S; Alix-Panabières, C; Pantel, K
Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity.
EMBO Mol Med. 2020; 12(9):e11908-e11908
Doi: 10.15252/emmm.201911908
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Chen, S; Tauber, G; Langsenlehner, T; Schmölzer, LM; Pötscher, M; Riethdorf, S; Kuske, A; Leitinger, G; Kashofer, K; Czyż, ZT; Polzer, B; Pantel, K; Sedlmayr, P; Kroneis, T; El-Heliebi, A
In Vivo Detection of Circulating Tumor Cells in High-Risk Non-Metastatic Prostate Cancer Patients Undergoing Radiotherapy.
Cancers (Basel). 2019; 11(7):
Doi: 10.3390/cancers11070933
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Dahlem, C; Barghash, A; Puchas, P; Haybaeck, J; Kessler, SM
The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer.
Int J Mol Sci. 2019; 20(13):
Doi: 10.3390/ijms20133204
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
de Wit, S; Rossi, E; Weber, S; Tamminga, M; Manicone, M; Swennenhuis, JF; Groothuis-Oudshoorn, CGM; Vidotto, R; Facchinetti, A; Zeune, LL; Schuuring, E; Zamarchi, R; Hiltermann, TJN; Speicher, MR; Heitzer, E; Terstappen, LWMM; Groen, HJM
Single tube liquid biopsy for advanced non-small cell lung cancer.
Int J Cancer. 2019; 144(12): 3127-3137.
Doi: 10.1002/ijc.32056
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Marcuello, M; Vymetalkova, V; Neves, RPL; Duran-Sanchon, S; Vedeld, HM; Tham, E; van Dalum, G; Flügen, G; Garcia-Barberan, V; Fijneman, RJ; Castells, A; Vodicka, P; Lind, GE; Stoecklein, NH; Heitzer, E; Gironella, M
Circulating biomarkers for early detection and clinical management of colorectal cancer.
MOL ASPECTS MED. 2019; 69(9): 107-122.
Doi: 10.1016/j.mam.2019.06.002
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Riethdorf, S; Hildebrandt, L; Heinzerling, L; Heitzer, E; Fischer, N; Bergmann, S; Mauermann, O; Waldispühl-Geigl, J; Coith, C; Schön, G; Peine, S; Schuler, G; Speicher, MR; Moll, I; Pantel, K
Detection and Characterization of Circulating Tumor Cells in Patients with Merkel Cell Carcinoma.
CLIN CHEM. 2019; 65(3): 462-472.
Doi: 10.1373/clinchem.2018.297028
Web of Science
PubMed
FullText
FullText_MUG
Suppan, C; Brcic, I; Tiran, V; Mueller, HD; Posch, F; Auer, M; Ercan, E; Ulz, P; Cote, RJ; Datar, RH; Dandachi, N; Heitzer, E; Balic, M
Untargeted Assessment of Tumor Fractions in Plasma for Monitoring and Prognostication from Metastatic Breast Cancer Patients Undergoing Systemic Treatment.
Cancers (Basel). 2019; 11(8):
Doi: 10.3390/cancers11081171
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Trapp, E; Janni, W; Schindlbeck, C; Jückstock, J; Andergassen, U; de Gregorio, A; Alunni-Fabbroni, M; Tzschaschel, M; Polasik, A; Koch, JG; Friedl, TWP; Fasching, PA; Haeberle, L; Fehm, T; Schneeweiss, A; Beckmann, MW; Pantel, K; Mueller, V; Rack, B; Scholz, C; SUCCESS Study Group
Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis.
J Natl Cancer Inst. 2019; 111(4):380-387
Doi: 10.1093/jnci/djy152
Web of Science
PubMed
FullText
FullText_MUG
Agarwal, A; Balic, M; El-Ashry, D; Cote, RJ
Circulating Tumor Cells: Strategies for Capture, Analyses, and Propagation.
Cancer J. 2018; 24(2):70-77
Doi: 10.1097/PPO.0000000000000310
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Alunni-Fabbroni, M; Majunke, L; Trapp, EK; Tzschaschel, M; Mahner, S; Fasching, PA; Fehm, T; Schneeweiss, A; Beck, T; Lorenz, R; Friedl, TWP; Janni, W; Rack, B; SUCCESS Study Group
Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
BMC Cancer. 2018; 18(1):141-141
Doi: 10.1186/s12885-018-4020-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Chen, S; El-Heliebi, A; Schmid, J; Kashofer, K; Czyż, ZT; Polzer, BM; Pantel, K; Kroneis, T; Sedlmayr, P
Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization.
J Vis Exp. 2018; (135):
Doi: 10.3791/56394
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
de Wit, S; Manicone, M; Rossi, E; Lampignano, R; Yang, L; Zill, B; Rengel-Puertas, A; Ouhlen, M; Crespo, M; Berghuis, AMS; Andree, KC; Vidotto, R; Trapp, EK; Tzschaschel, M; Colomba, E; Fowler, G; Flohr, P; Rescigno, P; Fontes, MS; Zamarchi, R; Fehm, T; Neubauer, H; Rack, B; Alunni-Fabbroni, M; Farace, F; De Bono, J; IJzerman, MJ; Terstappen, LWMM
EpCAMhigh and EpCAMlow circulating tumor cells in metastatic prostate and breast cancer patients.
Oncotarget. 2018; 9(86):35705-35716
Doi: 10.18632/oncotarget.26298
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
El-Heliebi, A; Hille, C; Laxman, N; Svedlund, J; Haudum, C; Ercan, E; Kroneis, T; Chen, S; Smolle, M; Rossmann, C; Krzywkowski, T; Ahlford, A; Darai, E; von Amsberg, G; Alsdorf, W; König, F; Löhr, M; de Kruijff, I; Riethdorf, S; Gorges, TM; Pantel, K; Bauernhofer, T; Nilsson, M; Sedlmayr, P
In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor Cells.
Clin Chem. 2018; 64(3):536-546
Doi: 10.1373/clinchem.2017.281295
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Markou, A; Lazaridou, M; Paraskevopoulos, P; Chen, S; Świerczewska, M; Budna, J; Kuske, A; Gorges, TM; Joosse, SA; Kroneis, T; Zabel, M; Sedlmayr, P; Alix-Panabières, C; Pantel, K; Lianidou, ES
Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients.
Clin Chem. 2018; 64(2):297-306
Doi: 10.1373/clinchem.2017.275503
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schochter, F; Rack, B; Tzschaschel, M; Polasik, A; Andergassen, U; Trapp, E; Alunni-Fabbroni, M; Schneeweiss, A; Müller, V; Pantel, K; Gade, J; Lorenz, R; Rezai, M; Tesch, H; Soeling, U; Fehm, T; Mahner, S; Schindlbeck, C; Lichtenegger, W; Beckmann, MW; Fasching, PA; Janni, W; Friedl, TWP; SUCCESS Study Group
Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study.
Oncol Res Treat. 2018; 41(3):93-98
Doi: 10.1159/000485566
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Benezeder, T; Tiran, V; Treitler, AAN; Suppan, C; Rossmann, C; Stoeger, H; Cote, RJ; Datar, RH; Balic, M; Dandachi, N
Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patients.
Oncotarget. 2017; 8(54):92483-92496
Doi: 10.18632/oncotarget.21426
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Chen, S; El-Heliebi, A; Kroneis, T
Biological and Molecular Characterization of Circulating Tumor Cells: A Creative Strategy for Precision Medicine?
Adv Clin Chem. 2017; 82(6):71-103
Doi: 10.1016/bs.acc.2017.06.001
Web of Science
PubMed
FullText
FullText_MUG
Dandachi, N; Tiran, V; Lindenmann, J; Brcic, L; Fink-Neuboeck, N; Kashofer, K; Absenger, G; Bezan, A; Cote, RJ; Datar, R; Balic, M
Frequency and clinical impact of preoperative circulating tumor cells in resectable non-metastatic lung adenocarcinomas.
Lung Cancer. 2017; 113(46):152-157
Doi: 10.1016/j.lungcan.2017.10.003
Web of Science
PubMed
FullText
FullText_MUG
Heitzer, E; Perakis, S; Geigl, JB; Speicher, MR
The potential of liquid biopsies for the early detection of cancer.
NPJ Precis Oncol. 2017; 1(1):36-36
Doi: 10.1038/s41698-017-0039-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Perakis, S; Speicher, MR
Emerging concepts in liquid biopsies.
BMC Med. 2017; 15(1):75-75
Doi: 10.1186/s12916-017-0840-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schramm, A; Schochter, F; Friedl, TWP; de Gregorio, N; Andergassen, U; Alunni-Fabbroni, M; Trapp, E; Jaeger, B; Heinrich, G; Camara, O; Decker, T; Ober, A; Mahner, S; Fehm, TN; Pantel, K; Fasching, PA; Schneeweiss, A; Janni, W; Rack, BK; SUCCESS Study Group
Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
Clin Breast Cancer. 2017; 17(4):279-285
Doi: 10.1016/j.clbc.2016.11.008
Web of Science
PubMed
FullText
FullText_MUG
Suppan, C; Balic, M
Early stage breast cancer treatment and prognostic factors: Post San Antonio Breast Cancer Symposium 2016.
Memo. 2017; 10(2):82-85
Doi: 10.1007/s12254-017-0328-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Trapp, EK; Majunke, L; Zill, B; Sommer, H; Andergassen, U; Koch, J; Harbeck, N; Mahner, S; Friedl, TWP; Janni, W; Rack, B; Alunni-Fabbroni, M
LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.
Mol Oncol. 2017; 11(11):1508-1526
Doi: 10.1002/1878-0261.12111
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Ulz, P; Heitzer, E; Geigl, JB; Speicher, MR
Patient monitoring through liquid biopsies using circulating tumor DNA.
Int J Cancer. 2017; 141(5):887-896
Doi: 10.1002/ijc.30759
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Heitzer, E; Ulz, P; Geigl, JB; Speicher, MR
Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsies.
Mol Oncol. 2016; 10(3):494-502
Doi: 10.1016/j.molonc.2015.12.004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hepp, P; Andergassen, U; Jäger, B; Trapp, E; Alunni-Fabbroni, M; Friedl, TW; Hecker, N; Lorenz, R; Fasching, P; Schneeweiss, A; Fehm, T; Janni, W; Rack, B
Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial.
Anticancer Res. 2016; 36(9):4771-4776
Doi: 10.21873/anticanres.11034
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hofman, P; Popper, HH
Pathologists and liquid biopsies: to be or not to be?
Virchows Arch. 2016; 469(6):601-609
Doi: 10.1007/s00428-016-2004-z
Web of Science
PubMed
FullText
FullText_MUG
Jueckstock, J; Rack, B; Friedl, TW; Scholz, C; Steidl, J; Trapp, E; Tesch, H; Forstbauer, H; Lorenz, R; Rezai, M; Häberle, L; Alunni-Fabbroni, M; Schneeweiss, A; Beckmann, MW; Lichtenegger, W; Fasching, PA; Pantel, K; Janni, W; SUCCESS Study Group
Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
BMC Cancer. 2016; 16(10):401-401
Doi: 10.1186/s12885-016-2454-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
König, A; Vilsmaier, T; Rack, B; Friese, K; Janni, W; Jeschke, U; Andergassen, U; Trapp, E; Jückstock, J; Jäger, B; Alunni-Fabbroni, M; Friedl, T; Weissenbacher, T; SUCCESS STUDY GROUP
Determination of Interleukin-4, -5, -6, -8 and -13 in Serum of Patients with Breast Cancer Before Treatment and its Correlation to Circulating Tumor Cells.
Anticancer Res. 2016; 36(6):3123-3130
Web of Science
PubMed
Pantel, K; Speicher, MR
The biology of circulating tumor cells.
Oncogene. 2016; 35(10):1216-1224
Doi: 10.1038/onc.2015.192
Web of Science
PubMed
FullText
FullText_MUG
Rack, B; Zombirt, E; Trapp, E; Jückstock, J; Andergassen, U; Neugebauer, J; Kost, B; Weissenbacher, T; Jeschke, U; Schindlbeck, C; Janni, W; Alunni-Fabbroni, M
Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients.
Oncology. 2016; 90(4):232-238
Doi: 10.1159/000442986
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schramm, A; Friedl, TW; Schochter, F; Scholz, C; de Gregorio, N; Huober, J; Rack, B; Trapp, E; Alunni-Fabbroni, M; Müller, V; Schneeweiss, A; Pantel, K; Meier-Stiegen, F; Hartkopf, A; Taran, FA; Wallwiener, D; Janni, W; Fehm, T
Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.
Arch Gynecol Obstet. 2016; 293(2):271-281
Doi: 10.1007/s00404-015-3879-7
Web of Science
PubMed
FullText
FullText_MUG
Speicher, MR; Gerger, A; Hoefler, G
Liquid biopsies. A multidisciplinary challenge for human geneticists, oncologists, and pathologists
MED GENET-BERLIN. 2016; 28(2): 245-250.
Doi: 10.1007/s11825-016-0090-6
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Todenhöfer, T; Hennenlotter, J; Dorner, N; Kühs, U; Aufderklamm, S; Rausch, S; Bier, S; Mischinger, J; Schellbach, D; Hauch, S; Feniuk, N; Bedke, J; Gakis, G; Stenzl, A; Schwentner, C
Transcripts of circulating tumor cells detected by a breast cancer-specific platform correlate with clinical stage in bladder cancer patients.
J Cancer Res Clin Oncol. 2016; 142(5):1013-1020
Doi: 10.1007/s00432-016-2129-0
Web of Science
PubMed
FullText
FullText_MUG
Ulz, P; Geigl, JB; Speicher, MR; Heitzer, E
Latest technological developments in the analysis of circulating tumor DNA
MED GENET-BERLIN. 2016; 28(2): 234-244.
Doi: 10.1007/s11825-016-0089-z
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Heidary, M; Auer, M; Ulz, P; Heitzer, E; Petru, E; Gasch, C; Riethdorf, S; Mauermann, O; Lafer, I; Pristauz, G; Lax, S; Pantel, K; Geigl, JB; Speicher, MR
The dynamic range of circulating tumor DNA in metastatic breast cancer.
Breast Cancer Res. 2014; 16(4):421-421
Doi: 10.1186/s13058-014-0421-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Müller, C; Holtschmidt, J; Auer, M; Heitzer, E; Lamszus, K; Schulte, A; Matschke, J; Langer-Freitag, S; Gasch, C; Stoupiec, M; Mauermann, O; Peine, S; Glatzel, M; Speicher, MR; Geigl, JB; Westphal, M; Pantel, K; Riethdorf, S
Hematogenous dissemination of glioblastoma multiforme.
Sci Transl Med. 2014; 6(247):247ra101-247ra101
Doi: 10.1126/scitranslmed.3009095
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Nastały, P; Ruf, C; Becker, P; Bednarz-Knoll, N; Stoupiec, M; Kavsur, R; Isbarn, H; Matthies, C; Wagner, W; Höppner, D; Fisch, M; Bokemeyer, C; Ahyai, S; Honecker, F; Riethdorf, S; Pantel, K
Circulating tumor cells in patients with testicular germ cell tumors.
Clin Cancer Res. 2014; 20(14):3830-41
Doi: 10.1158/1078-0432.CCR-13-2819
Web of Science
PubMed
FullText
FullText_MUG
Balic, M; Williams, A; Lin, H; Datar, R; Cote, RJ
Circulating Tumor Cells: From Bench to Bedside.
Annu Rev Med. 2013; 64(7):31-44
Doi: 10.1146/annurev-med-050311-163404
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
El-Heliebi, A; Kroneis, T; Zöhrer, E; Haybaeck, J; Fischereder, K; Kampel-Kettner, K; Zigeuner, R; Pock, H; Riedl, R; Stauber, R; Geigl, JB; Huppertz, B; Sedlmayr, P; Lackner, C
Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?
J Transl Med. 2013; 11(10):214-214
Doi: 10.1186/1479-5876-11-214
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Heitzer, E; Auer, M; Gasch, C; Pichler, M; Ulz, P; Hoffmann, EM; Lax, S; Waldispuehl-Geigl, J; Mauermann, O; Lackner, C; Höfler, G; Eisner, F; Sill, H; Samonigg, H; Pantel, K; Riethdorf, S; Bauernhofer, T; Geigl, JB; Speicher, MR
Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing.
Cancer Res. 2013; 73(10):2965-2975
Doi: 10.1158/0008-5472.CAN-12-4140
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Heitzer, E; Auer, M; Ulz, P; Geigl, JB; Speicher, MR
Circulating tumor cells and DNA as liquid biopsies.
Genome Med. 2013; 5(8):73-73
Doi: 10.1186/gm477
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Balic, M; Lin, H; Williams, A; Datar, RH; Cote, RJ
Progress in circulating tumor cell capture and analysis: implications for cancer management.
Expert Rev Mol Diagn. 2012; 12(3):303-312
Doi: 10.1586/erm.12.12
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Mathiesen, RR; Fjelldal, R; Liestl, K; Due, EU; Geigl, JB; Riethdorf, S; Borgen, E; Rye, IH; Schneider, IJ; Obenauf, AC; Mauermann, O; Nilsen, G; Christian Lingjaerde, O; Brresen-Dale, AL; Pantel, K; Speicher, MR; Naume, B; Baumbusch, LO
High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer.
Int J Cancer. 2012; 131(4):E405-E415
Doi: 10.1002/ijc.26444
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Rink, M; Chun, FK; Dahlem, R; Soave, A; Minner, S; Hansen, J; Stoupiec, M; Coith, C; Kluth, LA; Ahyai, SA; Friedrich, MG; Shariat, SF; Fisch, M; Pantel, K; Riethdorf, S
Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study.
Eur Urol. 2012; 61(4):810-7
Doi: 10.1016/j.eururo.2012.01.017
Web of Science
PubMed
FullText
FullText_MUG
Todenhöfer, T; Hennenlotter, J; Feyerabend, S; Aufderklamm, S; Mischinger, J; Kühs, U; Gerber, V; Fetisch, J; Schilling, D; Hauch, S; Stenzl, A; Schwentner, C
Preliminary experience on the use of the Adnatest® system for detection of circulating tumor cells in prostate cancer patients.
Anticancer Res. 2012; 32(8):3507-3513
Web of Science
PubMed
Weitere 50 Treffer anzeigen